Dry Eye clinical trials

Explore recruiting dry eye clinical trials.

Recruiting dry eye studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Dry Eye trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Randomized, double-blind, parallel group clinical trial to evaluate the efficacy and safety of PRGF eye drops as a treatment for dry eye disease in patients with glaucoma

Spain

Phase III and phase IV (Integrated) EU CTIS Study details

Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Phase IIB Clinical Trial to evaluate the efficacy and safety of Allogeneic Mesenchymal Stem Cell (MSC) eye injection treatment as therapy for Graft-versus-Host Disease (GvHD) refractory to conventional treatments

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel Group Study With 4 Weeks of Follow-Up to Evaluate Safety and Efficacy of a new formulation of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution at two different Concentrations in patients with Dry Eye Disease (REDUCO study)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomized, parallel-group, double-blind clinical trial to evaluate the efficacy and safety of PRGF eye drops in patients with dry eye disease

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Randomized, parallel-group, double-blind clinical trial to evaluate the efficacy and safety of PRGF eye drops in patients with dry eye disease

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Dry Eye trials by city

Dry Eye in Toronto Dry Eye in Vancouver Dry Eye in Montreal Dry Eye in Calgary Dry Eye in Edmonton Dry Eye in Ottawa Dry Eye in Winnipeg Dry Eye in Quebec City Dry Eye in Hamilton Dry Eye in Kitchener Dry Eye in London Dry Eye in Halifax Dry Eye in New York Dry Eye in Los Angeles Dry Eye in Chicago Dry Eye in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease